A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project — Miquel Bioque (2015) | RDL Network
A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project
Article 2015 en
Authors
MB
Miquel Bioque
AL
Adrián LLerena
BC
Bibiana Cabrera
Abstract
1 min read
These data indicate that the overall pharmacologic prescription for treating a first episode of psychosis in Spain follows the clinical practice guideline recommendations, and, together with security issues, support future research of determinate pharmacological strategies for the treatment of early phases of psychosis, such as the role of clozapine, long-acting injectable antipsychotics, antipsychotic combination, and the use of benzodiazepines.
Derek Clougher, María Florencia Forte, Gisela Mezquida, Ana M. Sánchez-Torres, Maria Serra‐Navarro, Rafael Penadés, António Lobo, Ana González‐Pinto, Rocío Panadero, Alexandra Roldán, Eduard Vieta, Elena de la Serna, Amira Trabsa, Anabel Martínez‐Arán, Carla Torrent, Alfonso Tortorella, Giulia Menculini, Josep Antoni Ramos‐Quiroga, Manuel J Cuesta, Miquel Bernardo, Sílvia Amoretti, S. Salmerón, Néstor Arbelo,
Christian Núñez, Christian Stephan‐Otto, Judith Usall, Miquel Bioque, António Lobo, Ana González‐Pinto, Laura Pina‐Camacho, Eduard Vieta, Josefina Castro‐Fornieles, Roberto Rodríguez–Jiménez, Anna Butjosa, Joost Janssen, Bibiana Cabrera, Mara Parellada, Miquel Bernardo, Gisela Mezquida, Sílvia Amoretti, Elisa Rodríguez-Toscano, Yasser Alemán‐Gómez, Eric P. Zorrilla, Sainza García, Concepción De‐la‐Cámara, Fe Barcones,
Discussion(0)
No comments yet. Be the first to comment.